McGuire Investment Group LLC Sells 85 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

McGuire Investment Group LLC decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating) by 0.3% during the second quarter, HoldingsChannel reports. The fund owned 24,802 shares of the medical equipment provider’s stock after selling 85 shares during the quarter. McGuire Investment Group LLC’s holdings in Intuitive Surgical were worth $4,978,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of ISRG. BlackRock Inc. raised its holdings in Intuitive Surgical by 197.3% during the 4th quarter. BlackRock Inc. now owns 26,538,660 shares of the medical equipment provider’s stock valued at $9,535,341,000 after acquiring an additional 17,612,768 shares during the period. State Street Corp increased its holdings in shares of Intuitive Surgical by 209.4% in the fourth quarter. State Street Corp now owns 14,834,746 shares of the medical equipment provider’s stock worth $5,330,124,000 after purchasing an additional 10,040,407 shares during the period. Capital World Investors increased its holdings in shares of Intuitive Surgical by 165.4% in the fourth quarter. Capital World Investors now owns 9,658,541 shares of the medical equipment provider’s stock worth $3,470,421,000 after purchasing an additional 6,018,962 shares during the period. Alliancebernstein L.P. increased its holdings in shares of Intuitive Surgical by 238.2% in the fourth quarter. Alliancebernstein L.P. now owns 6,287,228 shares of the medical equipment provider’s stock worth $2,259,001,000 after purchasing an additional 4,428,375 shares during the period. Finally, Jennison Associates LLC increased its holdings in shares of Intuitive Surgical by 124.8% in the first quarter. Jennison Associates LLC now owns 5,473,854 shares of the medical equipment provider’s stock worth $1,651,352,000 after purchasing an additional 3,038,455 shares during the period. Institutional investors own 82.44% of the company’s stock.

Insider Buying and Selling

In related news, Director Amal M. Johnson sold 6,375 shares of the stock in a transaction dated Thursday, September 8th. The shares were sold at an average price of $210.76, for a total value of $1,343,595.00. Following the completion of the transaction, the director now directly owns 11,224 shares of the company’s stock, valued at $2,365,570.24. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In related news, EVP Myriam Curet sold 9,000 shares of the stock in a transaction dated Wednesday, July 27th. The shares were sold at an average price of $225.00, for a total value of $2,025,000.00. Following the completion of the transaction, the executive vice president now directly owns 217 shares of the company’s stock, valued at $48,825. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Amal M. Johnson sold 6,375 shares of the firm’s stock in a transaction that occurred on Thursday, September 8th. The shares were sold at an average price of $210.76, for a total transaction of $1,343,595.00. Following the transaction, the director now directly owns 11,224 shares of the company’s stock, valued at approximately $2,365,570.24. The disclosure for this sale can be found here. Insiders sold a total of 101,162 shares of company stock valued at $22,062,916 over the last three months. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Morgan Stanley decreased their price target on shares of Intuitive Surgical from $300.00 to $225.00 and set an “equal weight” rating on the stock in a report on Friday, July 15th. The Goldman Sachs Group decreased their price target on shares of Intuitive Surgical from $319.00 to $273.00 and set a “buy” rating on the stock in a report on Friday, July 29th. Raymond James cut their target price on shares of Intuitive Surgical from $294.00 to $255.00 in a research report on Friday, July 22nd. Evercore ISI cut their target price on shares of Intuitive Surgical from $210.00 to $175.00 in a research report on Friday, July 22nd. Finally, Piper Sandler upped their target price on shares of Intuitive Surgical from $255.00 to $260.00 and gave the stock an “overweight” rating in a research report on Thursday, August 18th. Six equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $268.00.

Intuitive Surgical Stock Down 0.3 %

Shares of NASDAQ:ISRG traded down $0.56 during midday trading on Friday, hitting $190.52. 72,527 shares of the stock traded hands, compared to its average volume of 1,720,567. The stock has a market capitalization of $68.04 billion, a PE ratio of 48.62, a P/E/G ratio of 5.43 and a beta of 1.31. The business’s 50 day moving average is $219.31 and its two-hundred day moving average is $233.72. Intuitive Surgical, Inc. has a one year low of $186.83 and a one year high of $369.69.

Intuitive Surgical (NASDAQ:ISRGGet Rating) last released its quarterly earnings results on Thursday, July 21st. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.04 by ($0.19). Intuitive Surgical had a return on equity of 12.04% and a net margin of 24.05%. The company had revenue of $1.52 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the previous year, the company earned $1.42 earnings per share. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 3.76 earnings per share for the current year.

Intuitive Surgical Company Profile

(Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Read More

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.